In this multicentre , double-blind trial , between Oct @ , @ , and Oct @ , @ , we enrolled patients with HCV genotype @ and compensated cirrhosis who had not achieved SVR after successive treatments with pegylated interferon and protease-inhibitor regimens at @ sites in France .